N-[2-[3-[2-[(1,5-dimethylpyrazol-3-yl)amino]-5-methylpyrimidin-4-yl]-1H-indol-7-yl]-3-oxo-1H-isoindol-4-yl]cyclohexanecarboxamide
C33H34N8O2 — CID 170673251
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-[3-[2-[(1,5-dimethylpyrazol-3-yl)amino]-5-methylpyrimidin-4-yl]-1H-indol-7-yl]-3-oxo-1H-isoindol-4-yl]cyclohexanecarboxamide
N-[2-[3-[2-[(1,5-dimethylpyrazol-3-yl)amino]-5-methylpyrimidin-4-yl]-1H-indol-7-yl]-3-oxo-1H-isoindol-4-yl]cyclohexanecarboxamide (PubChem CID 170673251) has the molecular formula C33H34N8O2 and a molecular weight of 574.69 g/mol. Its IUPAC name is N-[2-[3-[2-[(1,5-dimethylpyrazol-3-yl)amino]-5-methylpyrimidin-4-yl]-1H-indol-7-yl]-3-oxo-1H-isoindol-4-yl]cyclohexanecarboxamide.
Molecular Properties
| Compound Name | N-[2-[3-[2-[(1,5-dimethylpyrazol-3-yl)amino]-5-methylpyrimidin-4-yl]-1H-indol-7-yl]-3-oxo-1H-isoindol-4-yl]cyclohexanecarboxamide |
|---|---|
| PubChem CID | 170673251 |
| Molecular Formula | C33H34N8O2 |
| Molecular Weight | 574.69 g/mol |
| Exact Mass | 574.28 |
| IUPAC Name | N-[2-[3-[2-[(1,5-dimethylpyrazol-3-yl)amino]-5-methylpyrimidin-4-yl]-1H-indol-7-yl]-3-oxo-1H-isoindol-4-yl]cyclohexanecarboxamide |
| SMILES | Cc1cnc(Nc2cc(C)n(C)n2)nc1-c1c[nH]c2c(N3Cc4cccc(NC(=O)C5CCCCC5)c4C3=O)cccc12 |
| InChI | InChI=1S/C33H34N8O2/c1-19-16-35-33(37-27-15-20(2)40(3)39-27)38-29(19)24-17-34-30-23(24)12-8-14-26(30)41-18-22-11-7-13-25(28(22)32(41)43)36-31(42)21-9-5-4-6-10-21/h7-8,11-17,21,34H,4-6,9-10,18H2,1-3H3,(H,36,42)(H,35,37,38,39) |
| InChIKey | AWEBBCLMAPNOBF-UHFFFAOYSA-N |
| XLogP | 6.40 |
| TPSA | 120.83 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 43 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 574.69 |
| LogP ≤ 5 | 6.40 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 170673251 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.